Migraine medication for preventing acute mountain sickness
Treatments studied
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests whether a migraine medication (Fremanezumab) can help prevent acute mountain sickness when going to high altitude. If it works, it might make high-altitude trips safer and more comfortable for healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You are generally healthy with no major illnesses (heart, lung, diabetes, chronic headaches, etc.)
- You live at an altitude lower than 1,000 meters (about 3,280 feet)
- You have not been above 2,000 meters (about 6,560 feet) in the last 8 weeks
- You can take the study medication (no allergies to it, no medications that could interfere)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the migraine prevention drug fremanezumab can reduce the number of migraines you get around your period. It is for women who have regular cycles and migraines that are clearly linked to their menstrual period.
This trial tests how acetazolamide affects your body's fluid levels at high altitude. It might help understand if the drug can prevent altitude sickness.
This program lets children and teens who finished a previous fremanezumab study keep receiving the medication. It is designed to provide continued treatment access under their doctor's supervision.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study looks at whether a natural substance called amylin can trigger migraine attacks in people who get migraines without aura. If you join, you'll receive an infusion and be monitored to see if you get a migraine, which could help researchers understand migraine causes.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
Hear when a new Acute Mountain Sickness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.